• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自噬阻断通过上调膀胱癌程序性死亡配体-1增强癌症相关免疫抑制。

Autophagy blockade potentiates cancer-associated immunosuppression through programmed death ligand-1 upregulation in bladder cancer.

机构信息

Division of Urology, Department of Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.

Division of Urology, School of Medicine, Fu-Jen Catholic University, New Taipei, Taiwan.

出版信息

J Cell Physiol. 2022 Sep;237(9):3587-3597. doi: 10.1002/jcp.30817. Epub 2022 Jul 29.

DOI:10.1002/jcp.30817
PMID:35903922
Abstract

A high basal level of autophagic flux in bladder cancer (BC) cells prevents cell death and weakens chemotherapy efficacy. However, how autophagy influences cancer-associated immunosuppression in BC remains undetermined. In this study, we observed a negative correlation between the autophagy-related markers LC3-II and programmed death ligand-1 (PD-L1) in BC cells. The autophagy inhibitors chloroquine (CQ) and bafilomycin A1 (Baf-A1) increased PD-L1 expression in BC cells through the ERK-JNK-c-Jun signal-transduction pathway. Moreover, the treatment of BC cells with CQ and Baf-A1 inhibited hsa-microRNA-34a (miR-34a) expression and miR-34a overexpression in BC cells prevented the autophagy blockade-induced PD-L1 expression; a negative correlation between miR-34a and PD-L1 expression was observed during treatment with autophagy inhibitors. Furthermore, miR-34a overexpression induced the cytotoxic activity of natural killer cells against BC cells. Our results provide evidence that autophagy blockade and its regulatory pathway affect cancer-associated immunosuppression through PD-L1 elevation. Thus, the coadministration of autophagy inhibitors and a PD-L1 immune checkpoint blockade provides a potential therapeutic approach for treating BC.

摘要

在膀胱癌 (BC) 细胞中,高基础自噬通量可防止细胞死亡并削弱化疗效果。然而,自噬如何影响 BC 中的癌症相关免疫抑制仍未确定。在本研究中,我们观察到 BC 细胞中的自噬相关标志物 LC3-II 和程序性死亡配体-1 (PD-L1) 呈负相关。自噬抑制剂氯喹 (CQ) 和巴弗洛霉素 A1 (Baf-A1) 通过 ERK-JNK-c-Jun 信号转导通路增加 BC 细胞中的 PD-L1 表达。此外,CQ 和 Baf-A1 处理 BC 细胞可抑制 hsa-微 RNA-34a (miR-34a) 的表达,而 miR-34a 在 BC 细胞中的过表达可防止自噬阻断诱导的 PD-L1 表达;在用自噬抑制剂治疗期间观察到 miR-34a 和 PD-L1 表达之间呈负相关。此外,miR-34a 的过表达诱导自然杀伤细胞对 BC 细胞的细胞毒性活性。我们的研究结果提供了证据表明,自噬阻断及其调节途径通过上调 PD-L1 影响癌症相关免疫抑制。因此,自噬抑制剂和 PD-L1 免疫检查点抑制剂的联合给药为治疗 BC 提供了一种潜在的治疗方法。

相似文献

1
Autophagy blockade potentiates cancer-associated immunosuppression through programmed death ligand-1 upregulation in bladder cancer.自噬阻断通过上调膀胱癌程序性死亡配体-1增强癌症相关免疫抑制。
J Cell Physiol. 2022 Sep;237(9):3587-3597. doi: 10.1002/jcp.30817. Epub 2022 Jul 29.
2
Bladder cancer cell-intrinsic PD-L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy.膀胱癌固有 PD-L1 信号促进 mTOR 和自噬的激活,抑制这些信号可以改善细胞毒性化疗。
Cancer Med. 2021 Mar;10(6):2137-2152. doi: 10.1002/cam4.3739. Epub 2021 Feb 24.
3
Cisplatin contributes to programmed death-ligand 1 expression in bladder cancer through ERK1/2-AP-1 signaling pathway.顺铂通过 ERK1/2-AP-1 信号通路促进膀胱癌中程序性死亡配体 1 的表达。
Biosci Rep. 2019 Sep 6;39(9). doi: 10.1042/BSR20190362. Print 2019 Sep 30.
4
YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1.YY1 诱导的长非编码 RNA PSMA3 反义 RNA 1 作为竞争性内源性 RNA,通过调节程序性细胞死亡配体 1,促进膀胱癌细胞的活力并抑制其凋亡。
Bioengineered. 2021 Dec;12(2):9150-9161. doi: 10.1080/21655979.2021.1994907.
5
Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.miR-424-5p 通过靶向 PD-L1 并调节 PTEN/PI3K/AKT/mTOR 信号通路抑制乳腺癌细胞中的肿瘤发生活性。
Life Sci. 2020 Oct 15;259:118239. doi: 10.1016/j.lfs.2020.118239. Epub 2020 Aug 10.
6
[Effect of autophagy on expression of neutrophil programmed death ligand-1 in mice with sepsis].[自噬对脓毒症小鼠中性粒细胞程序性死亡配体-1表达的影响]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Sep;31(9):1091-1096. doi: 10.3760/cma.j.issn.2095-4352.2019.09.007.
7
Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas.EB 病毒编码的 EBNA2 通过下调 B 细胞淋巴瘤中的 miR-34a 来改变免疫检查点 PD-L1 的表达。
Leukemia. 2019 Jan;33(1):132-147. doi: 10.1038/s41375-018-0178-x. Epub 2018 Jun 26.
8
Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells.甲磺酸萘莫司他,一种丝氨酸蛋白酶抑制剂,抑制干扰素-γ诱导的人癌细胞程序性死亡配体 1 的上调。
Int Immunopharmacol. 2018 Jan;54:39-45. doi: 10.1016/j.intimp.2017.10.016. Epub 2017 Oct 28.
9
Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells.顺铂通过激活人膀胱癌细胞中的BECN1诱导保护性自噬。
Drug Des Devel Ther. 2017 May 16;11:1517-1533. doi: 10.2147/DDDT.S126464. eCollection 2017.
10
A Feedback Loop Formed by ATG7/Autophagy, FOXO3a/miR-145 and PD-L1 Regulates Stem-Like Properties and Invasion in Human Bladder Cancer.由ATG7/自噬、FOXO3a/miR-145和PD-L1形成的反馈环调节人膀胱癌的干细胞样特性和侵袭能力。
Cancers (Basel). 2019 Mar 12;11(3):349. doi: 10.3390/cancers11030349.

引用本文的文献

1
Autophagy in tumor immune escape and immunotherapy.自噬在肿瘤免疫逃逸与免疫治疗中的作用
Mol Cancer. 2025 Mar 19;24(1):85. doi: 10.1186/s12943-025-02277-y.
2
Epigenetic modifications in bladder cancer: crosstalk between DNA methylation and miRNAs.膀胱癌中的表观遗传修饰:DNA甲基化与微小RNA之间的相互作用
Front Immunol. 2025 Feb 5;16:1518144. doi: 10.3389/fimmu.2025.1518144. eCollection 2025.
3
Pharmacology Progresses and Applications of Chloroquine in Cancer Therapy.氯喹在癌症治疗中的药理学进展和应用。
Int J Nanomedicine. 2024 Jul 5;19:6777-6809. doi: 10.2147/IJN.S458910. eCollection 2024.
4
Homogeneous polysaccharide exerts anti-bladder cancer effects via autophagy induction.均相多糖通过诱导自噬发挥抗膀胱癌作用。
Pharm Biol. 2024 Dec;62(1):214-221. doi: 10.1080/13880209.2024.2316195. Epub 2024 Feb 14.
5
Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response.利用 EMT 功能克服癌症耐药性:一个调节转移的因子决定化疗反应。
Cancer Metastasis Rev. 2024 Mar;43(1):457-479. doi: 10.1007/s10555-023-10162-7. Epub 2024 Jan 16.
6
Exploiting autophagy balance in T and NK cells as a new strategy to implement adoptive cell therapies.利用 T 细胞和自然杀伤细胞中的自噬平衡作为实施过继细胞疗法的新策略。
Mol Cancer. 2023 Dec 9;22(1):201. doi: 10.1186/s12943-023-01893-w.
7
/MicroRNA-34 axis in cancer and beyond.癌症及其他领域中的微小RNA-34轴
Heliyon. 2023 Apr 3;9(4):e15155. doi: 10.1016/j.heliyon.2023.e15155. eCollection 2023 Apr.
8
Tumor suppressive functions of hsa‑miR‑34a on cell cycle, migration and protective autophagy in bladder cancer.hsa-miR-34a 在膀胱癌中的细胞周期、迁移和保护性自噬中的肿瘤抑制功能。
Int J Oncol. 2023 May;62(5). doi: 10.3892/ijo.2023.5514. Epub 2023 Apr 21.
9
Non-coding RNAs: The recently accentuated molecules in the regulation of cell autophagy for ovarian cancer pathogenesis and therapeutic response.非编码RNA:卵巢癌发病机制和治疗反应中细胞自噬调控方面最近受到更多关注的分子。
Front Pharmacol. 2023 Mar 31;14:1162045. doi: 10.3389/fphar.2023.1162045. eCollection 2023.
10
Nanoparticles augment the therapeutic window of RT and immunotherapy for treating cancers: pivotal role of autophagy.纳米颗粒增强了 RT 和免疫疗法治疗癌症的治疗窗口:自噬的关键作用。
Theranostics. 2023 Jan 1;13(1):40-58. doi: 10.7150/thno.77233. eCollection 2023.